Connect your AI

Aptiv APTV Gain (loss) on deconsolidation of subsidiary

Gain (loss) on deconsolidation of subsidiary at other companies

Roivant SciencesROIV

$2.76M+255%

BridgeBio PharmaBBIO

$0-100%

ArganAGX

$87.25K—

Lamar AdvertisingLAMR

-$9K—

Lennox InternationalLII

$225K+160%

Roivant SciencesROIV

$0-100%

Segments

By segment

Electrical Distribution Systems$0—

Engineered Components Group$0—

Other financials

Income statement

Revenue$5.1B+5.4%

Gross profit$920.0M0.0%

Operating income$378.0M-15.6%

Net income$189.0M+1,818%

EPS (diluted)$0.88+1,860%

Balance sheet

Cash & equivalents$3.2B+188%

Total debt$9.9B+17.1%

Total equity$9.2B+3.0%

Total assets$25.2B+9.1%

Cash flow

Operating cash flow-$143.0M-152%

CapEx$219.0M+11.2%

Free cash flow-$362.0M-576%

Valuation

Market cap$13.48B+8.4%

Enterprise value$20.19B+2.5%

P/E36.9×+28.9×

P/S0.7×0.0×

Profitability

Gross margin18.9%-0.2pp

Operating margin5.4%-4.1pp

Net margin1.8%-6.2pp

FCF margin5.3%-3.4pp

Returns & leverage

Return on equity4%-11.5pp

Debt / equity1.1×+0.1×

Current ratio2.1×+0.5×